Belle charges no membership fees—all costs are medication-inclusive. Semaglutide runs $199 month-to-month or $119/month prepaid over six months; tirzepatide $249 monthly or $199/month prepaid. Here's how the plans compare.

Belle's public pricing is organized by subscription length, not dose tier. As of September 2026, no published policy confirms whether Belle raises prices when a patient's semaglutide or tirzepatide dose is titrated up.

Belle offers month-to-month billing and prepaid 2-month or 6-month plans for both semaglutide and tirzepatide. The 6-month plan cuts the effective per-month cost by 32–40% over monthly billing, but requires upfront payment and a 6-month commitment.

Belle offers three billing tiers—monthly subscription, two-month prepaid, and six-month prepaid—with lower per-month rates for upfront commitments. We compare the true 12-month cost of each option against flat month-to-month alternatives.

Belle charges $249/month for compounded tirzepatide on a rolling basis, or $199/month prepaid over six months. We walk through every plan option, calculate 12-month costs, and compare Belle's structure to PlexusDx.

Belle charges $199 per month for compounded semaglutide on a month-to-month plan, or $119 per month effective when six months are prepaid. This breakdown deconstructs plans, upfront costs, and 12-month totals.

Moving from Belle to PlexusDx requires timing your last Belle dose with your first PlexusDx shipment. This guide walks through the logistics, compares like-for-like pricing, and explains what a licensed provider reviews when you apply.

Belle charges $199/month for semaglutide or $249/month for tirzepatide on month-to-month billing, with prepaid discounts down to $119 and $199 per month equivalent. No membership fee. We break down the full structure, compare 12-month costs, and show where PlexusDx fits.

PlexusDx charges less for semaglutide month-to-month, while Belle charges less for tirzepatide. We compare both compounds, month-to-month and prepaid options, over 12 months.